Pharmacists at the University of North Carolina (UNC) are increasing access to biomarker-driven cancer treatments via close collaboration with physicians in community clinics.
“Our goal is to increase access to therapies, whether through successful advocacy of off-label use or enrolling patients in a clinical trial,” said Amber Cipriani, PharmD, BCOP, a precision medicine pharmacy coordinator at the UNC Eshelman School of Pharmacy, in Chapel Hill. Whichever access